HORIZON THERAPEUTICS PUB L's ticker is HZNP and the CUSIP is G46188101. A total of 494 filers reported holding HORIZON THERAPEUTICS PUB L in Q4 2020. The put-call ratio across all filers is 0.36 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $20,028,523 | -27.4% | 173,122 | -35.5% | 0.02% | -28.0% |
| Q2 2023 | $27,598,495 | -23.7% | 268,337 | -19.0% | 0.02% | -26.5% |
| Q1 2023 | $36,160,701 | -54.6% | 331,324 | -52.7% | 0.03% | -56.4% |
| Q4 2022 | $79,678,905 | -15.2% | 700,166 | -53.9% | 0.08% | -20.4% |
| Q3 2022 | $94,013,000 | +145.3% | 1,519,040 | +216.2% | 0.10% | +151.3% |
| Q2 2022 | $38,322,000 | -2.7% | 480,463 | +28.4% | 0.04% | +18.2% |
| Q1 2022 | $39,381,000 | +6.2% | 374,307 | +8.5% | 0.03% | +13.8% |
| Q4 2021 | $37,092,000 | -22.4% | 344,930 | -21.1% | 0.03% | -31.0% |
| Q3 2021 | $47,829,000 | +17.0% | 437,319 | +0.0% | 0.04% | +16.7% |
| Q2 2021 | $40,883,000 | +3.2% | 437,218 | +1.4% | 0.04% | -5.3% |
| Q1 2021 | $39,633,000 | +20.7% | 431,184 | -4.0% | 0.04% | +11.8% |
| Q4 2020 | $32,843,000 | +21.8% | 448,983 | +29.4% | 0.03% | +6.2% |
| Q3 2020 | $26,959,000 | +88.2% | 347,053 | +34.6% | 0.03% | +77.8% |
| Q2 2020 | $14,326,000 | +504.5% | 257,750 | +222.2% | 0.02% | +350.0% |
| Q1 2020 | $2,370,000 | -10.2% | 80,000 | +9.7% | 0.00% | +33.3% |
| Q4 2019 | $2,639,000 | +32.9% | 72,900 | 0.0% | 0.00% | +50.0% |
| Q3 2019 | $1,985,000 | – | 72,900 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Kopp Family Office, LLC | 544,835 | $57,322,000 | 30.98% |
| Paulson & Co. | 5,614,000 | $590,649,000 | 18.18% |
| Avoro Capital Advisors LLC | 6,500,000 | $683,865,000 | 12.48% |
| 1492 Capital Management LLC | 121,840 | $12,819,000 | 6.80% |
| Iron Triangle Partners LP | 503,744 | $52,999,000 | 6.30% |
| Tri Locum Partners LP | 132,332 | $13,923,000 | 5.44% |
| HealthCor Management, L.P. | 710,110 | $74,711,000 | 4.98% |
| Eversept Partners, LP | 609,939 | $64,171,682 | 4.93% |
| Bain Capital Public Equity Management II, LLC | 1,286,371 | $135,339,000 | 4.33% |
| PFM Health Sciences, LP | 1,091,840 | $114,872,000 | 4.30% |